On this page
Myopia (high, pathological)
This condition involves extreme elongation of the eyeball, leading to very blurred distance vision and increased risks of various eye complications, potentially affecting individuals of any age.
Overview
Pathological myopia, also known as high or degenerative myopia, represents a more severe form of short-sightedness than common myopia. Individuals with this condition have a very high refractive error, meaning their eyes cannot focus light correctly. This often results from the eyeball growing too long from front to back [PMID:33671408]. Unlike typical short-sightedness which usually stabilises in adulthood, pathological myopia can progressively worsen over time and is associated with structural changes within the eye. These changes can significantly impact vision and lead to serious complications.
Symptoms & clinical features
The primary symptom of pathological myopia is extremely blurred vision when looking at distant objects. This typically requires strong corrective lenses, such as glasses or contact lenses, to achieve clear vision. Beyond blurred distance vision, individuals may also experience 'floaters' - small specks or cobweb-like images that drift across the field of vision - or flashes of light, particularly if the retina is affected [PMID:33671408]. In more advanced stages, vision can become distorted or patchy due to complications affecting the back of the eye.
Video: Genetics 101
Affected organs
Pathological myopia primarily affects the eye, specifically the retina, choroid, and sclera (the white outer layer of the eyeball). The excessive elongation of the eyeball stretches and thins these delicate structures. The retina, which is responsible for detecting light and sending signals to the brain, is particularly vulnerable to damage. The choroid, a layer of blood vessels beneath the retina, can also be affected, impacting the retina's blood supply. These changes can lead to vision-threatening complications.
Risks & severity
The severity of pathological myopia can vary, but it carries a higher risk of serious eye complications compared to common myopia. These include retinal detachment, where the retina pulls away from its underlying support tissue; myopic macular degeneration, affecting central vision; glaucoma, a condition that damages the optic nerve; and cataracts, a clouding of the eye's lens [PMID:33671408]. The risk of these complications generally increases with the degree of short-sightedness and the extent of eye elongation. While the exact prevalence is not well established, some estimates suggest it affects around 5% of the general population. The condition can manifest at various ages, from childhood into adulthood, and progression can continue over many years.
Genetic causes
Pathological myopia is understood to have a complex genetic basis, meaning it is influenced by a combination of multiple genes and environmental factors [PMID:33671408]. Unlike conditions caused by changes in a single gene, there isn't one specific gene identified as the sole cause of pathological myopia in all cases. Instead, research suggests that various genetic predispositions, alongside environmental influences such as extensive near-work activities and limited outdoor time, contribute to the development and progression of the condition [PMID:33671408]. The exact mechanisms by which these genetic and environmental factors interact are still being investigated.
Inheritance pattern
Pathological myopia follows a polygenic or complex inheritance pattern. This means that multiple genes contribute to an individual's susceptibility, rather than a single gene being responsible. It also suggests that environmental factors play a significant role alongside genetic predisposition. Therefore, while a family history of pathological myopia may increase an individual's risk, the condition does not typically follow a straightforward inheritance pattern like autosomal dominant or recessive traits. Predicting the likelihood of developing the condition in relatives can be challenging due to this complex interplay.
Diagnosis & testing
Diagnosis of pathological myopia typically involves a comprehensive eye examination by an optometrist or ophthalmologist. This includes measuring visual acuity, assessing refractive error, and examining the internal structures of the eye, particularly the retina, using specialised equipment. Imaging techniques such as optical coherence tomography (OCT) may be used to assess the thickness and health of the retina and choroid [PMID:33671408]. If pathological myopia is suspected or diagnosed, individuals are usually referred to an ophthalmologist for further assessment and ongoing management. In the NHS, such referrals are typically managed through routine ophthalmology pathways, and a specific R-code for genetic testing for this complex condition is not usually required.
Management & lifestyle
Managing pathological myopia primarily focuses on correcting vision and monitoring for, and treating, potential complications. Corrective lenses (glasses or contact lenses) are essential for improving vision. Regular eye examinations are crucial to detect early signs of complications such as retinal detachment or myopic macular degeneration. Treatment for complications may include laser therapy or surgery, depending on the specific issue [PMID:33671408]. There are no specific genetic therapies available for pathological myopia, given its complex genetic architecture. Individuals should discuss their specific management plan with their ophthalmologist. Lifestyle considerations, such as spending time outdoors and reducing prolonged near-work, may also be discussed as part of a broader management strategy for myopia progression, though their impact on established pathological myopia is less clear.
UK care pathway
In the UK, individuals with suspected or diagnosed pathological myopia would typically enter the NHS ophthalmology care pathway. Initial assessment often occurs through a local optometrist, who can then refer to an NHS ophthalmologist for specialist opinion and ongoing care. Genetic counselling is not routinely offered for pathological myopia due to its polygenic nature, but individuals with concerns about family history or specific genetic conditions should discuss this with their GP for a potential referral to clinical genetics services.
Frequently asked questions
What is the difference between common short-sightedness and pathological myopia?
Common short-sightedness usually stabilises in adulthood and has fewer risks. Pathological myopia is more severe, progressive, and involves structural changes to the eye, leading to a higher risk of serious vision-threatening complications.
Can pathological myopia be cured?
There is currently no cure for pathological myopia itself. Management focuses on correcting vision with lenses and treating or preventing complications. Research is ongoing into potential treatments to slow its progression.
Will my children inherit pathological myopia?
Pathological myopia has a complex inheritance pattern, meaning multiple genes and environmental factors are involved. While there may be an increased risk if it runs in your family, it doesn't follow a simple inheritance rule, and not all children will inherit it.
What are the common complications of pathological myopia?
Common complications include retinal detachment, myopic macular degeneration, glaucoma, and cataracts. Regular eye checks are important to monitor for these issues and address them promptly.
What should I do if I think I have pathological myopia?
If you experience very blurred distance vision, or symptoms like increased 'floaters' or flashes of light, you should arrange an eye examination with an optometrist. They can assess your vision and refer you to an ophthalmologist if needed.